A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
Clinical trial NCT04543617 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04543617
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2027-03-31
- Enrollment
- 760
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.